Inner Balance vs Midi Health: Which One Fits Your Situation?

The HRT Index Editorial TeamIndependent women's health research

Last reviewed:August 10, 2026

Editorial research — not medically reviewed by a clinician. Why this label

Last updated: August 10, 2026 · Last verified: August 10, 2026 · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

Have a PPO card or want a live clinician visit?

The article found Midi Health to be the better first move for most women, especially when PPO coverage, a live visit, or FDA-approved prescription options matter. This is a sponsored link; the comparison also explains where Inner Balance may fit.

Check Midi coverage and self-pay pricing

Inner Balance vs Midi Health has a clear default: Midi Health for most women. It is in-network with most PPO plans, uses a live clinician visit, and usually prescribes FDA-approved medication; self-pay is $250 initially and $150 per follow-up, plus medication. Inner Balance fits women who specifically want bundled cash-pay compounded Oestra: $199 monthly for six months, then $99.50.

Best for most women: Midi Health, especially if you have usable PPO coverage, want a live visit, or want the option to fill an FDA-approved prescription at your own pharmacy.

Best for a narrower fit: Inner Balance, if you deliberately want its combined compounded vaginal estradiol-and-progesterone cream, no insurance billing, and the standard medication bundled into one monthly price.

Not for you right now: either online path as the first move if you have new, unexplained bleeding after menopause. That needs prompt gynecologic evaluation.

Our money, on the table: Midi Health may pay us a commission if you book through a qualifying link. Inner Balance pays us nothing on this page. We have still published the honest case for Inner Balance, the strongest verified limitation against Midi, and the claim conflicts we found on Inner Balance’s own pages. You should weigh all of it, including us.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

The 30-second version

Decision factor	Inner Balance (Oestra)	Midi Health	Evidence status
What you are buying	A recurring care-and-medication subscription centered on Oestra	A clinician visit and care plan; prescriptions and labs are separate	Verified August 10, 2026
Core medication model	One combined compounded vaginal estradiol-and-progesterone cream	Multiple routes and medication types; usually FDA-approved products, plus a separate compounded Custom Rx line	Verified / provider-stated
FDA status	Oestra is compounded and is not FDA-approved as a finished product	Depends on the prescription; many standard HRT options are FDA-approved, while Custom Rx and testosterone offerings may be compounded	Verified; confirm the exact prescription
Insurance	Does not bill insurance; its terms say patients agree not to submit claims	In-network with most PPO plans; plan-specific copays, deductibles, and coinsurance may apply	Verified August 10, 2026
Self-pay price	$199/month for the first six months, then $99.50/month	$250 initial visit; $150 continued-care visit	Verified August 10, 2026
Medication included	Standard Oestra prescription and shipping are included; dose changes, labs, or additional prescriptions may cost extra	No; pharmacy medication is separate	Verified
Visit format	Online questionnaire, checkout, then clinician review; no scheduled video visit is required	Scheduled virtual visit with a clinician	Verified
Labs to begin	Provider says routine labs are optional; a clinician may still order testing	Not universally required for general menopause care; a clinician may order bloodwork or imaging. Testosterone care includes laboratory steps	Verified / depends on treatment
Refund promise	Up to six months of subscription fees, with two deadlines and exclusions	No published satisfaction guarantee for completed clinical visits found	Verified August 10, 2026
Medicaid / Medi-Cal	Cash-pay service; no insurance claims	Midi says it cannot treat Medicaid or Medi-Cal patients, even as self-pay	Verified
Medicare	Cash-pay; terms prohibit claim submission	Not covered; Medicare beneficiaries may self-pay but cannot submit Midi-related claims	Verified
State availability	Available only where the service and its clinicians can legally operate; confirm during intake	General virtual care is advertised nationwide; specific products, including testosterone, have narrower availability	Confirm for your state and treatment

Source: Midi pricing and insurance, Midi’s care process, Midi Custom Rx, Midi testosterone, Inner Balance treatment page, Inner Balance FAQ, Inner Balance terms, and Inner Balance refund policy. All were checked August 10, 2026.

How we label evidence throughout this page:

Verified — a current primary source supports it and we found no current contradiction.
Provider-stated — the company publishes it, but we could not independently test or confirm it.
Sources conflict — the company’s own current pages say materially different things.
Confirm before paying — the answer depends on your state, plan, prescription, clinician, or checkout terms.
Calculated by us — The HRT Index did the math using the provider’s current published prices.

Inner Balance vs Midi Health: what is the actual difference?

Inner Balance sells you a standardized product-centered pathway. Midi Health sells you a broader clinician-centered pathway. Inner Balance’s core service is Oestra, a combined compounded estradiol-and-progesterone vaginal cream shipped in a 90-day supply. Midi starts with a virtual clinician visit and can prescribe different routes, products, and nonhormonal options based on the visit.

Read that again, because it is the thing that makes this whole comparison click.

You are not comparing two prices. You are comparing two purchases.

Everyone puts $199 a month next to $250 a visit and calls it a comparison. It is not.

The $199 Inner Balance headline includes the standard Oestra prescription and shipping. The $250 Midi number covers the initial clinical visit; medication, and any ordered labs, are separate. One price recurs monthly while you stay subscribed. The other is charged when a visit occurs.

Comparing them straight across is like comparing a gym membership to a personal-training session. Both cost money. They are not the same transaction.

Once you see that, most of the confusion dissolves. The real question is not simply which is cheaper? It is:

Do you already want Inner Balance’s specific product model, or do you want a prescriber who can help choose among multiple routes and products?

For someone who deliberately wants Oestra and the bundled cash-pay structure, Inner Balance has a coherent appeal. For someone who wants a clinician to evaluate the history and help choose among a patch, pill, gel, vaginal product, nonhormonal medication, or no prescription at all, Midi is the broader path.

Where each model puts the risk

Every model has a weak point. These two put the uncertainty in different places.

With Inner Balance, the risk sits in paying before the clinician review and then relying on the cancellation and refund rules. Inner Balance’s FAQ says a candidate moves from the health quiz to checkout, after which a provider reviews the information. Its terms allow Inner Balance not to accept the agreement and return subscription fees, but the public pages do not publish a guaranteed return timeline for a clinically declined order. Confirm that timing before paying.

With Midi, the risk sits in the bill. A clinician evaluates you before prescribing, but “in-network” does not mean “free.” Your deductible, coinsurance, copay, pharmacy benefit, lab network, and prescription formulary can all change what you owe.

Neither of those is a scandal. They are different places to get surprised.

Inner Balance publishes a first-party comparison cluster

Inner Balance currently publishes multiple comparison and review pages featuring itself, including an Inner Balance vs Midi Health page, a Midi Health review, and multi-provider comparisons involving Midi, Winona, Evernow, Alloy, and Inner Balance.

That is legal, common, and visible from the domain and byline. Some of the material is useful. But it is still first-party marketing, not an independent second opinion.

You deserved to know that before treating several pages as several independent votes. And you deserve to know that Midi may pay us—which is exactly why we show the underlying prices, terms, conflicts, and third-party records instead of asking you to trust a verdict.

Start here before you compare anything else
Both companies leave questions unanswered on their public pages. We built the exact 12-question checklist you can use before paying either one.
→ See the 12 questions to ask before you pay
No signup. Copy it into a portal message, insurer call, or appointment note.

Which one is right for your situation?

Choose Midi Health if you have usable PPO coverage, want a live clinical conversation, need route flexibility, or want to request an FDA-approved product. Choose Inner Balance if you have already decided that its bundled compounded vaginal formulation is the model you want and you accept cash-pay subscription terms. New postmenopausal bleeding belongs with an in-person evaluation first.

Midi Health is likely your answer if:

You have PPO insurance or an employer benefit that includes Midi.
You want a scheduled video conversation before a prescription is selected.
You want to fill a standard prescription at your own pharmacy.
You want a medication with FDA-reviewed labeling and are prepared to confirm the exact product prescribed.
You are not sure whether a patch, pill, gel, cream, ring, vaginal insert, nonhormonal prescription, or another route fits you.
You want a provider who can order bloodwork or imaging when your history calls for it.
You want testosterone discussed and live in an eligible state. Midi says its women’s testosterone program is available in 25 states; it uses compounded testosterone, requires clinical qualification and laboratory steps, and testosterone is a Schedule III controlled substance that requires a prescription.

Inner Balance is likely your answer if:

You have no usable insurance coverage, or you have decided not to involve an insurer.
You want the standard medication and shipping bundled into a published monthly subscription price.
You do not want a scheduled video appointment.
You specifically want a combined compounded vaginal estradiol-and-progesterone cream.
You have already discussed FDA-approved options and have a patient-specific reason to consider a compounded route or formulation.
You are comfortable getting the exact strength, compounding pharmacy, refund treatment, and monitoring plan confirmed in writing.

Neither online path is the first move if:

You have new, unexplained bleeding after menopause. Current ACOG guidance treats postmenopausal bleeding as a condition that needs prompt diagnostic evaluation. An online subscription is not a substitute for the imaging, examination, or endometrial assessment your clinician may recommend.
You need an urgent evaluation, physical examination, Pap test, biopsy, or imaging now. Neither service is emergency care, and telehealth cannot perform those procedures.
Your history requires coordination that the service cannot provide. A personal history of breast or endometrial cancer, blood clots, significant liver disease, or another complex risk factor does not automatically make all online menopause care impossible—but it does make individualized clinician review and, in some cases, specialist or oncology coordination essential.
You are on Medicaid or Medi-Cal and are considering Midi. Midi’s policy says it cannot treat you, even as a self-pay patient. Use your covered network or another eligible clinical route instead.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Did neither list feel fully like you?
That is normal. Your uterus status, bleeding history, medication route, cancer or clot history, coverage, and state can change the answer.
→ Get your personal starting-point plan with Find My HRT Path
Free. It does not diagnose or prescribe.

How much does Inner Balance vs Midi Health actually cost?

For the first 90 days, Inner Balance is $597 if all three monthly payments are collected for its shipped 90-day supply. Midi self-pay is $400 for an initial visit plus one continued-care visit, before medication or labs. With PPO coverage, Midi’s visit cost depends on your copay, deductible, and coinsurance—not one universal number.

First 90 days, side by side

Cost component	Inner Balance	Midi with PPO	Midi self-pay
Clinical care / access	Included in subscription	Your plan’s cost-sharing for two visits	$400 ($250 + $150)
Medication	Standard Oestra included	Your pharmacy benefit or cash price	Cash price at your pharmacy
Shipping	Included	Depends on pharmacy or product	Depends on pharmacy or product
Routine starting labs	Provider says optional; ordered testing can cost extra	Only if ordered; coverage and network rules apply	Only if ordered; self-pay or insurer rate applies
90-day modeled total	$597	Visit cost-sharing + medication + any labs	$400 + medication + any labs

Assumptions: The 90-day window begins with the first payment. The Midi example includes one initial visit and one follow-up because follow-up frequency is individualized. It does not assume laboratory testing. Inner Balance’s FAQ says each shipment contains a three-month supply and billing is monthly; its terms say a reactivation fee may apply if someone receives three months and cancels before payment is collected for all three months.

The Inner Balance long game

The interesting number is not the eventual $99.50 rate. It is what you have actually paid by the time that rate arrives.

Time enrolled	Calculation	Total paid	Average per month
90 days	3 × $199	$597	$199.00
6 months	6 × $199	$1,194	$199.00
12 months	(6 × $199) + (6 × $99.50)	$1,791	$149.25
24 months	(6 × $199) + (18 × $99.50)	$2,985	$124.38

Calculated by The HRT Index from Inner Balance’s published August 10, 2026 pricing. These are costs if you remain enrolled for the stated period; they are not a claim that the public terms impose a six-month contractual commitment.

That distinction matters. Inner Balance says cancel anytime. The first six months are still expensive if you stay, but “six-month introductory price” is not the same thing as “you are locked into six months.”

Two additional costs are easy to miss:

The treatment page says dose adjustments may incur an additional cost.
The terms say additional prescriptions, recommended tests, and a prescription filled at a pharmacy you choose may create separate charges.

So Inner Balance offers a more predictable headline cost—not a promise that nothing can ever be added.

The Midi formula

Midi does not publish a monthly membership price because it bills by visit.

Midi self-pay total = $250 initial visit + ($150 × continued-care visits) + medication + ordered labs or imaging

Care pattern	Visit cost	Not included
Initial evaluation only	$250	Medication, labs, imaging
Initial + 1 continued-care visit	$400	Medication, labs, imaging
Initial + 2 continued-care visits	$550	Medication, labs, imaging
Initial + 3 continued-care visits	$700	Medication, labs, imaging
With PPO insurance	Cannot be reduced to one number	Your cost depends on plan rules and the prescription

There is no mandatory monthly membership charge in Midi’s published standard pricing. Future visits, medication, and testing are still billable when they occur.

The medication number we will not fake

A single “Midi medication cost” would be fiction. It changes by product, strength, quantity, brand or generic status, pharmacy, ZIP code, deductible, formulary, prior authorization, and discount program. The honest comparison is to look up the exact prescription after your clinician names it—or call your insurer before filling it.

One small pricing conflict that tells you something bigger

Inner Balance’s current treatment page says $99.50 per month after month six. Some of its comparison content rounds that ongoing amount to $99, and one first-year estimate has been published as approximately $1,788.

Using the treatment-page price, the first-year total is $1,791.

It is a three-dollar difference. Nobody is being financially destroyed by three dollars. But it is a clean demonstration of why the treatment page and checkout terms—not a comparison article, theirs or ours—should control your final number.

Have a PPO card?
Your coverage result is the largest cost variable in this comparison. Check the plan, then confirm the result with both Midi and your insurer before the appointment.
→ Check Midi’s current coverage and self-pay pricing
(Midi may pay The HRT Index a commission if you book through a qualifying link.)

Can you use insurance, HSA, or FSA with either one?

Midi is in-network with most PPO plans, but coverage and out-of-pocket cost vary. Inner Balance does not bill insurance, and its terms say patients agree not to submit claims themselves. Both advertise HSA/FSA payment options, but Inner Balance’s own refund and HSA/FSA pages conflict on whether those purchases qualify for a refund.

Four terms that should never be mashed together

Term	What it means	Inner Balance	Midi Health
Bills insurance	Provider submits a medical claim	No	Yes, for many PPO plans
Accepts HSA/FSA card	You use tax-advantaged funds at checkout	Yes, for Oestra according to provider page	Yes for eligible services according to provider payment options
Out-of-network reimbursement	You pay, then submit a claim	Terms say you agree not to submit claims	Depends on the service and plan; confirm before assuming
Money-back guarantee	Company refunds under its own policy	Yes, with deadlines and exclusions	No published satisfaction guarantee for completed visits found

HSA/FSA acceptance is not insurance acceptance. It means the payment method may be accepted. It does not prove that your plan administrator will approve every expense or that the transaction is automatically substantiated.

Inner Balance’s insurance answer is more than “no”

Inner Balance’s terms say the service does not participate with or bill commercial insurance, Medicare, or Medicaid. They also say the patient agrees not to submit claims to government programs or private insurers and agrees to indemnify Inner Balance for losses resulting from a submitted claim.

That is a material contract term. Read it before you pay.

The fair context: cash-pay telehealth services often use no-claim language when they are not enrolled with an insurer or federal program. The existence of a no-claim clause is not, by itself, evidence that a business is illegitimate. The important point is practical: do not buy Inner Balance assuming you can later turn it into an out-of-network reimbursement.

The HSA/FSA contradiction you need in writing

Two current Inner Balance pages say opposite things:

Current Inner Balance page	Published rule
Refund policy	Refund eligibility requires self-pay and does not list HSA/FSA payment as an exclusion
HSA/FSA page	HSA/FSA purchases are nonrefundable and are not valid under the six-month guarantee

Source: Sources conflict.* We are not choosing which page controls, because only Inner Balance can do that.

If the guarantee is the reason you feel safe trying Oestra, get the HSA/FSA refund rule in writing before using that card.

That sentence is worth more than a page full of vague reassurance.

Keep your FSA documentation anyway

Inner Balance’s HSA/FSA page says that a direct card payment means no receipt submission is needed. That may be true when a transaction is automatically substantiated by the plan’s card system. It is not a universal promise for every health FSA.

IRS Publication 969 says health FSA expenses must be substantiated by independent third-party information, and a plan can require documentation when the transaction is not automatically substantiated. IRS Publication 502 includes prescribed medicines and drugs within medical expenses, but your plan administrator controls the final payment and documentation process.

Download the receipt, the prescription documentation, and any letter of medical necessity. “The card went through” and “the plan will never ask me for proof” are not the same sentence.

Medicare and Medicaid

Midi and Medicaid/Medi-Cal: Midi says it cannot treat patients enrolled in Medicaid or Medi-Cal, even if they want to self-pay.

Midi and Medicare: Midi is not covered by Medicare or Medicare-related plans. It says Medicare beneficiaries may be seen as self-pay patients but cannot submit claims related to Midi visits, medications, or associated services.

Inner Balance: Its service is cash-pay and its terms prohibit submitting claims to commercial or government payers.

For a reader who already has Medicaid or Medicare drug coverage, the strongest first move is usually to investigate covered clinicians and covered FDA-approved prescriptions before voluntarily moving the whole transaction outside the benefit.

A visit and a drug are separate coverage questions

This is the structural insight that makes the insurance section easier:

Will the clinical visit be covered?
Will the exact prescription be covered?

With Midi, those questions can have different answers. A visit may be in-network while a particular brand is nonformulary, or the visit may hit your deductible while the generic prescription is inexpensive.

With Inner Balance’s standard pathway, the public price bundles Oestra and the care subscription into a cash-pay model. Its terms also preserve patient pharmacy choice, but say Inner Balance may continue charging for services while the outside pharmacy cost becomes additional. That is why you should ask whether the standard bundled pathway or an outside-pharmacy pathway would apply to your prescription before assuming one price covers every scenario.

Insurance is your deciding variable?
Do not decide from a logo wall. Check Midi, then call the number on your card and ask about the medical group, telehealth specialist cost-sharing, lab network, and prescription formulary.
→ Check current Midi coverage information

Is Oestra FDA-approved, and how much does that matter?

Oestra is a compounded prescription medication, so the finished product is not FDA-approved. Midi commonly prescribes FDA-approved menopause medications, but it also has compounded offerings. The difference involves premarket review, product labeling, evidence, manufacturing and quality oversight, and how much is known about the exact finished formula—not a claim that every compounded medication is unsafe.

“Bioidentical” does not mean “compounded”

This is the single most useful distinction in the section.

“Bioidentical” describes a hormone as chemically or structurally identical to a hormone made by the body. It does not tell you whether the finished medication is FDA-approved.

FDA-approved estradiol products and FDA-approved micronized progesterone products exist. Compounded preparations can also contain estradiol or progesterone. Those finished products do not have the same regulatory status.

So ask two separate questions:

What hormone is in it?
Did this exact finished product go through FDA approval?

What FDA says about compounding

FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness, or quality before marketing. FDA also recognizes that compounding can meet an important patient need when an approved product is not medically appropriate—for example, because of an allergy or a needed dosage form.

The two main federal pathways are:

Section 503A: traditional patient-specific compounding, generally centered on state pharmacy oversight and not subject to federal current good manufacturing practice requirements in the same way as 503B facilities.
Section 503B: an outsourcing facility that registers with FDA, is primarily overseen by FDA, is inspected on a risk-based schedule, and is subject to current good manufacturing practice requirements.

Neither pathway makes the finished compounded drug FDA-approved. Registration is not approval, and it is not proof that a facility has never had a compliance problem.

Inner Balance currently says both 503A and 503B

Sources conflict — verified August 10, 2026
Inner Balance’s menopause treatment page displays a “503A U.S. pharmacy” badge near the top. Farther down, the same page says Oestra is made by a 503B compounding pharmacy.
Those are different statutory categories. The public page does not identify the dispensing pharmacy in the text we could verify, so the conflict cannot be resolved from the page alone.

Do not guess which one is right. Ask:

“What is the legal name of the pharmacy dispensing my prescription, and is my order compounded under 503A or supplied by a registered 503B outsourcing facility?”

Then verify the facility with the relevant state board of pharmacy or FDA’s outsourcing-facility list.

FDA-approved and compounded: the practical comparison

Question	FDA-approved finished product	Compounded finished product
FDA premarket review of this exact product	Yes	No
Standardized FDA-approved prescribing information	Yes	No FDA-approved label for the compounded product
Product-specific dose and route studied for approval	Yes	Not required for FDA approval because the product is not FDA-approved
Manufacturer quality requirements	FDA-approved manufacturing requirements apply	Depends on 503A/503B pathway and facility oversight
Public product-specific evidence	Usually identifiable through labeling and approval records	May be limited, unpublished, or not specific to the actual formula
Patient-specific formulation possible	Limited to approved products and strengths	Yes, when legally and clinically appropriate

The legitimate lane for compounding

ACOG’s 2023 Clinical Consensus says compounded bioidentical menopause therapy should not be prescribed routinely when FDA-approved formulations exist. It also recognizes that compounding may be appropriate in some circumstances, including when an exact needed product, ingredient profile, or route is not commercially available. ACOG specifically notes that cost and access concerns may prompt consideration of compounded vaginal estrogen or progesterone formulations, with potency and vehicle quality discussed with the pharmacy.

The National Academies likewise concluded that compounded hormone therapy has a limited evidence base and should be reserved for specific patient needs rather than treated as a routine replacement for approved products.

That creates a real, legitimate lane for Inner Balance—but a narrow one:

You have a patient-specific need an approved product cannot meet.
A clinician documents why the compounded formulation is appropriate.
You understand that the exact finished product is not FDA-approved.
The dose, pharmacy, monitoring plan, beyond-use date, and refund terms are clear.

Preference matters in shared decision-making. It is not the same as evidence that two finished products are equivalent.

Does an FDA-approved combined vaginal estradiol-and-progesterone cream exist?

We found no current FDA-approved labeling for a fixed-dose combined estradiol-and-progesterone vaginal cream. The FDA-approved estradiol-and-progesterone combination verified for this review, Bijuva, is an oral capsule.

That means Midi cannot simply prescribe an FDA-approved product identical to Oestra’s claimed combined vaginal format. There is no verified approved one-for-one equivalent in that dosage form.

That is the strongest honest case for Inner Balance: it offers a formulation format that the approved market does not duplicate.

The strongest honest limit is the other side of the same fact: the exact Oestra formula does not have FDA-approved product labeling or the product-specific approval evidence that comes with an approved medicine.

What do we know about Oestra-specific studies?

As of August 10, 2026, our searches of PubMed, ClinicalTrials.gov, current FDA records, and Inner Balance’s public pages did not locate a product-specific, peer-reviewed pharmacokinetic or endometrial-safety study for the exact Oestra formulation.

That does not prove no internal data or unpublished testing exists. It means we could not verify a public study that tells a reader how this exact formula, strength, base, route, and schedule perform in the body.

The right question is not “Are estradiol and progesterone studied?” They are. The right question is:

“What evidence applies to this exact finished formula and dose?”

If you have a uterus, ask this out loud

Systemic estrogen exposure in a woman with a uterus raises the endometrial-protection question. The answer depends on the estrogen exposure, progestogen, dose, route, schedule, adherence, and patient factors.

A published ELITE analysis found that the particular vaginal progesterone schedule studied—45 mg daily for 10 days each month—was insufficient to completely oppose the endometrial effect of oral estradiol 1 mg daily. That study did not test Oestra, and it cannot establish Oestra’s safety or lack of safety. It does show why evidence cannot be transferred casually from one vaginal progesterone regimen to another.

Ask any provider, including Midi:

“I have a uterus. With this exact estrogen exposure and progesterone plan, what protects my uterine lining, and what bleeding or monitoring should trigger an evaluation?”

That is not alarmism. It is the question that turns “combined hormones” into an actual care plan.

Is the Inner Balance money-back guarantee real, and how do you get a refund?

The published guarantee is real, but it is not automatic. Inner Balance’s refund policy says you must request it through the Care Team, stay within six months of the original order, and submit the request within 14 days after cancellation. The refund is capped at up to six months of subscription fees and excludes listed products and services.

The refund steps, in order

Step	What the published policy requires	Why it matters
1	Cancel the subscription through the account / secure portal	Stopping future service is separate from asking for money back
2	Message the Care Team to initiate the refund	The policy does not make refunds automatic
3	Be within six months of the original order date	First deadline
4	Submit within 14 days after cancellation	Second deadline—the easy one to miss
5	Meet the self-pay eligibility rule	Reimbursement by an insurer or government payer disqualifies the request under the policy
6	Stay within the scope of the guarantee	Up to six months of Oestra subscription fees; labs, supplements, third-party services, Libida, and NAD+ are excluded

The most important line is step 4. Cancelling starts a 14-day request window. It does not itself submit the refund request.

“Cancel anytime” and “refund everything” are not synonyms

Keep this sentence:

“Cancel anytime” describes stopping future service. It does not promise that every payment, shipped prescription, HSA/FSA transaction, lab, supplement, or third-party service qualifies for a refund.

That rule applies to every subscription in this category, not just Inner Balance.

The HSA/FSA problem reaches the guarantee

The refund policy’s published eligibility language and the HSA/FSA page do not match. One page does not list HSA/FSA payment as an exclusion; the other says HSA/FSA purchases are nonrefundable and invalid under the guarantee.

If you plan to use HSA/FSA funds because the guarantee makes the purchase feel safe, get this answer before checkout:

“If I pay for Oestra with this HSA or FSA card, will the six-month guarantee apply? Please confirm in writing and identify the policy that controls.”

Midi has no comparable satisfaction guarantee

We found no published Midi money-back guarantee for a completed clinical visit. That is a negative if your priority is a satisfaction-based refund promise.

The model offers a different kind of protection: you pay for a clinical service, receive an evaluation, and a prescription is chosen only if the clinician considers it appropriate. You have not bought six months of medication before that conversation.

Different protection. Not a guarantee.

The refund promise is part of your decision?
Read the controlling policy before checkout, save a dated copy, and ask about HSA/FSA treatment in writing.
→ Read Inner Balance’s current refund policy
→ Jump to the pre-payment questions

What do reviews and complaint records actually show?

The independent review pools are not comparable in size. Midi had a 4.1 TrustScore from 1,526 Trustpilot reviews on August 10, 2026; Inner Balance had 3.1 from 15. Midi was BBB-accredited with a B rating and 161 complaints; Inner Balance was not accredited, had a B− rating, and 12 complaints. Counts need scale and context.

Keep the evidence pools separate

Evidence source	Inner Balance	Midi Health	What it can tell you
Company-owned review display	Provider publishes a 4.9/5 claim from thousands of reviews on its own site	Provider publishes testimonials but no directly comparable site-wide score in the pages reviewed	Marketing evidence; collection and moderation methods may differ
Trustpilot	3.1 from 15 reviews	4.1 from 1,526 reviews	Independent platform sentiment; sample size and review-selection effects still matter
BBB	Not accredited; B−; 12 complaints	Accredited; B; 161 complaints	Complaint handling and business-profile information—not clinical outcomes
NAD advertising record	None identified in this review	Midi permanently discontinued a challenged 91%-within-two-months claim; NAD did not decide the claim on its merits	Advertising-claim accuracy, not a medical safety ruling

Verified August 10, 2026 from Trustpilot’s Midi profile, Trustpilot’s Inner Balance profile, Midi’s BBB profile, Inner Balance’s BBB profile, and the NAD case summary.

The comparison that is not a comparison

Inner Balance’s Midi review compares Inner Balance’s own on-site review widget with Midi’s Trustpilot score. Those are different evidence pools with different collection conditions.

On the independent platform where both exact domains appear, the samples were 15 and 1,526. That does not prove the bigger company gives better care. It means a 15-review sample should not carry the same confidence as a four-digit sample.

A small review count is not evidence of a bad company. It is evidence that you have less independent review data.

The strongest documented weakness against Midi

Billing and insurance friction are the recurring practical risk. Midi itself warns that being in-network does not eliminate deductibles, coinsurance, or copays. BBB and Trustpilot complaints include allegations about unexpected charges, claim processing, customer support, and prescription or follow-up logistics.

Complaint allegations are not adjudicated clinical facts, and BBB does not verify every third-party statement. The pattern is still useful because it tells you what to prevent:

Verify the medical group is in-network for your exact plan and state.
Ask what you owe before the deductible is met.
Confirm laboratory network and billing.
Ask whether the assigned clinician can manage the treatment you are seeking.
Keep the insurer call reference number.

That is how you use a complaint record: not to declare a company guilty, but to make the known failure mode harder to happen to you.

The advertising action against Midi

On February 25, 2026, BBB National Programs’ National Advertising Division closed an inquiry concerning a Midi claim that 91% of patients found relief within two months. Midi told NAD it had permanently discontinued the challenged claims. NAD therefore did not review the claims on their merits and treated them, for compliance purposes, as though discontinuation had been recommended.

This was an advertising-claims matter. It was not a safety finding, a clinical misconduct ruling, or a conclusion that Midi’s care does not work.

The practical problem is that Inner Balance’s current Midi review and comparison content continued to cite the 91% figure after Midi had withdrawn it. That makes it a poor number for your decision, regardless of which company benefits from repeating it.

The record against Inner Balance

Inner Balance’s independent review and BBB profiles are much smaller. The recurring allegations include cancellation and refund friction, billing confusion, support responsiveness, and identity-verification timing.

The published refund policy confirms why some of that friction can occur: cancellation and refund are separate actions, and the refund request has a 14-day post-cancellation deadline.

There are also positive independent accounts of refunds being completed. One Trustpilot reviewer wrote that the refund process was “smooth and quick.” That is a service experience, not evidence of medical effectiveness—and it is exactly the kind of limited claim a testimonial can support.

One first-party service quote from Midi

Midi’s own pricing page publishes this customer statement:

“Midi was so easy: I got a same day appointment and they took my insurance.” — Victoria W.

That is Midi’s marketing, not proof of typical appointment speed or coverage. It is included because the ease-and-coverage promise is central to Midi’s appeal; the billing warnings above are the necessary counterweight.

The independent record does not erase Midi’s advantages: broader medication choice, live clinical evaluation, national general-care reach, and potential PPO coverage. It tells you not to confuse “accepted insurance” with “zero out-of-pocket cost.”

If billing variability would genuinely keep you up at night, Inner Balance’s published subscription is more predictable. That is a legitimate reason to choose it—provided you want the product, understand that it is compounded, and get the refund and pharmacy answers in writing.

A live visit and PPO coverage are what you want?
That points toward Midi. Confirm the plan and the treatment capability before the appointment, not after the bill.
→ See current Midi coverage and book a first visit
(Midi may pay The HRT Index a commission if you book through a qualifying link.)

What did we find when we checked Inner Balance’s claims against each other?

Inner Balance’s current pages contain material conflicts on the compounding pathway, HSA/FSA refunds, ongoing price, and how the refund promise is described. Its symptom-outcome percentages also vary by page and time frame. None of that proves fraud. It does mean the public marketing cannot answer several questions without written confirmation.

The verified conflict ledger

Topic	Current version A	Current version B	What to do
Compounding pathway	“503A U.S. pharmacy” badge	Same treatment page later says a 503B pharmacy	Ask for the dispensing pharmacy’s legal name and pathway
HSA/FSA refunds	Refund policy does not exclude HSA/FSA payment	HSA/FSA page says those purchases are nonrefundable and outside the guarantee	Get written confirmation before using the card
Ongoing monthly price	Treatment page: $99.50 after month six	Comparison content rounds to $99	Use treatment page and checkout terms
First-year total	Comparison content has used approximately $1,788	Treatment-page math is $1,791	Confirm checkout; use unrounded price
Guarantee headline	Marketing describes a six-month or 180-day money-back guarantee	Policy adds two deadlines, a portal request, scope limits, and exclusions	Follow the policy, not the headline
Symptom outcomes	Main treatment page currently shows figures including 98% and 80%	Comparison/review pages publish 97%, 80.2%, 78.7%, and similar numbers with different descriptions or time frames	Treat as provider internal data, not a clinical-trial result
Withdrawn Midi statistic	Current Inner Balance content cites Midi’s 91%-within-two-months number	Midi permanently discontinued the challenged claim during a February 2026 NAD inquiry	Do not use the number to choose either provider

The outcome statistics are provider internal data

Inner Balance publishes strong percentages and week-by-week result claims. The pages label at least some of these as internal data, but they do not provide a public peer-reviewed Oestra trial that allows a reader to inspect recruitment, sample size, attrition, outcome definitions, comparator, analysis, or adverse-event collection.

The current differences—98% versus 97%, or 80% versus 80.2%—are not automatically scandalous. Different cohorts, time points, questions, or rounding can create different values.

The practical conclusion is narrower:

Do not choose Oestra because one marketing percentage feels precise. Choose it only if the formulation, evidence limits, price, pharmacy, refund rules, and monitoring plan fit you.

“No added testosterone” is not the same as “contains testosterone”

Inner Balance says Oestra does not contain added testosterone and separately says progesterone can participate in the body’s hormone pathways. Those statements are not necessarily contradictory.

The clean factual version is: Oestra’s marketed active hormone combination is estradiol and progesterone, not testosterone. Any claim that this reliably raises testosterone or replaces a clinically indicated testosterone prescription would require evidence specific to the product and patient. Do not let pathway language turn into an ingredient claim.

The provider’s FDA-status language should not control yours

Inner Balance’s current treatment page uses strong efficacy language and describes the hormones as FDA-approved while discussing Oestra. That phrasing can blur the regulatory line between ingredients used in approved products and the compounded finished product.

Your decision should use the cleaner statement:

Oestra is a compounded finished product and is not FDA-approved.

That does not erase a legitimate patient-specific reason to compound. It prevents the reason from being built on a false equivalence.

What this means for you, practically

Not “this company is dishonest.” We cannot see intent, and fast-moving websites create inconsistencies without malice.

It means this:

You cannot resolve the final decision from marketing pages alone—not theirs, and not ours. You resolve it by asking specific questions, getting the answers in writing, and saving the version of the price or guarantee you relied on.

That is what the next section is for.

What should you ask before you pay either one?

Ask six questions of each company before money changes hands. Inner Balance’s questions close the gaps around formulation, pharmacy pathway, uterine protection, payment, and refunds. Midi’s questions close the gaps around network status, clinician capability, medication status, pharmacy cost, testing, and follow-up cadence.

Ask Inner Balance

What exact formulation and strength would I receive, and where will it appear on my prescription label?
What is the legal name of the dispensing pharmacy, and is my prescription handled under 503A or supplied by a registered 503B outsourcing facility?
I have a uterus. With this exact formula, what protects my uterine lining, and what bleeding or monitoring would trigger an evaluation?
If I pay with an HSA or FSA card, does the six-month guarantee still apply? Please send the controlling rule in writing.
What are the storage instructions, beyond-use date, dose in each application, and contact process for side effects or a missed shipment?
What happens to my payment if the clinician declines to prescribe, and how many business days does the return take?

Ask Midi

Is the medical group that will bill me in-network for my exact plan and state, and what is my estimated initial-visit cost before and after the deductible?
Can the clinician assigned to me manage the treatment I am seeking? This is especially important for testosterone, which is controlled and has narrower state and prescriber requirements.
Is the specific medication you are recommending FDA-approved or compounded? What is the product name, strength, route, and pharmacy?
What is the estimated cash price and my plan’s formulary cost for that exact prescription? Does it need prior authorization?
Will you order labs or imaging in my case, where will they be performed, and how will they be billed?
When should I expect the first follow-up, what does it cost, and which issues require a paid visit rather than portal messaging?

Ask your insurer

Write down the representative’s name, date, time, and call-reference number.

Is Midi’s billing medical group in-network for my plan in my state?
What is my telehealth specialist copay, deductible status, and coinsurance?
Does the visit need a referral or prior authorization?
Which laboratory is in-network, and will laboratory claims be billed separately?
Is the likely prescription on the formulary, and does it require step therapy or prior authorization?
If coverage is denied, what is the appeal route?

“In-network” does not mean “no bill.” It means the provider has a negotiated arrangement with the plan. If your deductible is unmet, you may owe much or all of the allowed amount.

Copy this checklist before you open another tab
It is the original decision asset on this page because it converts vague uncertainty into answerable pre-payment questions.
Still unsure which questions matter most for your history? → Use Find My HRT Path

What medications and routes can each provider actually offer?

Midi offers the wider clinical menu: multiple estrogen routes, progesterone, vaginal therapies, nonhormonal prescriptions, and selected compounded products. Inner Balance’s core HRT offer is Oestra, a compounded vaginal cream combining estradiol and progesterone. The trade is flexibility versus simplicity—not “good medicine” versus “bad medicine.”

What Midi can offer

Midi describes individualized virtual care that can include FDA-approved HRT in forms such as patches, pills, gels, creams, rings, and other vaginal products, along with micronized progesterone and nonhormonal options when appropriate.

It also operates Midi Custom Rx, a separate cash-pay line that includes compounded prescriptions for selected symptoms. That matters for accuracy: Midi is FDA-approved-leaning, not FDA-approved-only.

If FDA approval is your non-negotiable, say this in the visit:

“I want to consider FDA-approved products first. Tell me before prescribing if the option is compounded.”

Testosterone at Midi

Midi advertises a women’s testosterone program in 25 states. Its public process includes an initial visit, laboratory testing, a second visit, prescription if appropriate, and ongoing follow-up.

The regulatory facts are not optional:

Testosterone is a Schedule III controlled substance under federal law.
It requires a prescription and appropriate prescribing authority.
No testosterone product is FDA-approved specifically for treating menopausal symptoms in women in the United States.
Midi’s women’s testosterone offering uses compounded medication.

Do not book specifically for testosterone without confirming state availability, clinician authority, laboratory requirements, follow-up cost, and the pharmacy.

What Inner Balance offers

Inner Balance’s core HRT model is deliberately narrower: one daily compounded vaginal cream combining estradiol and progesterone, shipped after clinician approval, with portal-based clinical support.

For the right woman, that simplicity is the appeal. It reduces the number of separate prescriptions and removes the pharmacy trip in the standard pathway.

The trade-off is equally real: if you do not want a vaginal cream, want an FDA-approved finished product, need a different estrogen route, need a nonhormonal prescription, or want a live diagnostic conversation before checkout, Inner Balance’s core model does not offer the same breadth.

How the intakes differ

Step	Inner Balance	Midi Health
1	Complete online health quiz	Book visit and complete intake
2	Move to checkout if the quiz identifies you as a candidate	Attend live virtual clinician visit
3	Clinician reviews the submitted information	Clinician builds a care plan and prescribes if appropriate
4	Approved prescription is compounded and shipped	Standard prescription goes to a pharmacy; certain Custom Rx products may ship
5	Portal messaging, check-ins, refill coordination	Continued-care visits and messaging according to care plan

Inner Balance says compounding and shipment occur within 3–5 business days after approval, with most U.S. deliveries arriving 3–5 business days after shipment. That is a provider-stated timeline, not a guaranteed arrival date.

Switching from one to the other

Leaving Inner Balance for Midi: Check your refund deadlines before cancelling. Then cancel and separately submit the refund request within the policy window. Bring the prescription label, exact strength, application instructions, start date, bleeding history, and any side effects to Midi.

Leaving Midi for Inner Balance: Bring the same records. A formal records transfer may or may not be required, but “symptom-based care” is not a reason to hide prior prescriptions, doses, labs, or adverse effects. The next clinician needs the full treatment history to decide whether a compounded formulation is appropriate.

How did The HRT Index compare Inner Balance and Midi Health?

We read current provider prices, policies, intake descriptions, medication disclosures, insurance rules, and refund terms on August 10, 2026; checked medical and regulatory claims against FDA, ACOG, The Menopause Society, federal controlled-substance rules, IRS guidance, and peer-reviewed literature; and reviewed the same independent accountability sources for both companies.

The HRT Index Verification Standard

We use The HRT Index Verification Standard in the same five-pillar order for every provider comparison. There is no numeric score because a single number would hide the facts that change the decision.

1. Clinical legitimacy. Both pathways involve prescription medication and clinician review. We do not treat either as an over-the-counter product. We verify prescription requirements, public provider process, FDA status, compounding disclosures, and any controlled-substance rules. Inner Balance’s unresolved 503A/503B conflict is published rather than guessed.

2. Care quality. Midi uses a scheduled virtual visit and continued-care appointments. Inner Balance uses a questionnaire, checkout, post-checkout clinician review, and portal support. We treat those as different care models, not as automatic proof that one clinician is more competent than another.

3. Medication fit. Midi wins breadth. Inner Balance wins only for the reader who deliberately wants its combined compounded vaginal model. The exact product matters more than marketing categories such as “bioidentical.”

4. Price transparency. Inner Balance publishes a clear standard subscription price, but dose changes, additional prescriptions, outside pharmacy use, testing, and the HSA/FSA refund conflict prevent it from being one universal all-in number. Midi publishes clean visit prices but cannot publish your medication, lab, deductible, or coinsurance total.

5. Access. Midi advertises nationwide general care but excludes Medicaid/Medi-Cal patients and restricts specific programs such as testosterone by state. Inner Balance’s terms limit access to states where services are available, so state and clinician eligibility must be confirmed during intake.

What we actually verified

Midi’s current self-pay visit prices and PPO, Medicare, Medicaid, and Medi-Cal policies.
Inner Balance’s current standard Oestra pricing, shipment size, shipping timeline, dose-adjustment footnote, intake sequence, cancellation mechanism, terms, and refund deadlines.
The direct conflict between Inner Balance’s refund policy and HSA/FSA page.
The direct 503A/503B conflict on Inner Balance’s treatment page.
Midi’s separate Custom Rx line and current women’s testosterone program description.
FDA’s current explanation of compounded-drug status and 503A/503B oversight.
Federal Schedule III status for testosterone.
ACOG’s current compounded-hormone consensus and 2026 postmenopausal-bleeding update.
The ELITE endometrial analysis relevant to transferring claims between vaginal progesterone regimens.
Current Trustpilot, BBB, and NAD records for both companies where available.

What we could not verify

Which compounding pathway and legal pharmacy name applies to an individual Oestra prescription.
Which publicly stated Oestra strength or formulation any individual customer will receive.
Product-specific, peer-reviewed pharmacokinetic or endometrial-safety data for the exact Oestra formula.
Your eligibility, exact state access, appointment availability, insurance benefit, medication price, lab bill, or clinician assignment.
Whether Inner Balance will treat an HSA/FSA-funded Oestra purchase as refundable, because its own pages conflict.
Firsthand checkout, shipment, cancellation, or clinical experience. We did not enroll, pay, or pose as a patient.

What we did not do

We did not invent a patient story, publish a fake medical reviewer, create a numeric provider score, average incompatible review pools, or call a compounded product FDA-approved because its ingredients also appear in approved medicines.

We also did not turn a complaint allegation into a finding of wrongdoing. Complaints are signals about friction points; provider policies and authoritative records control factual claims.

Found something that changed? Prices, insurer contracts, state access, and policies move. Send The HRT Index the source and date so the page can be corrected and re-verified.

The verdict: which one should you actually choose?

For most women deciding between only these two, Midi Health is the better first move. It gives you a live clinical visit, broader treatment choice, the ability to request FDA-approved options, and possible PPO coverage. Inner Balance is the stronger fit for a narrower reader who deliberately wants bundled cash-pay Oestra and accepts the compounded-product and refund-policy uncertainties.

Choose Midi if…

You have usable PPO coverage or an employer benefit.
You want a live conversation before a medication is selected.
You want several routes or nonhormonal options considered.
You want to prioritize an FDA-approved finished product and confirm it by name.
You need a clinician who can order testing or coordinate a broader care plan.

Choose Inner Balance if…

You specifically want its combined compounded vaginal estradiol-and-progesterone cream.
You prefer a published cash-pay subscription over insurance billing variability.
You do not want a scheduled video visit.
You understand that Oestra is not FDA-approved and are prepared to verify the exact pharmacy, strength, monitoring plan, and guarantee treatment.
A clinician has identified a patient-specific reason that this formulation makes more sense than available approved options.

Choose neither, for now, if…

You have new bleeding after menopause.
You need an exam, imaging, biopsy, Pap test, or urgent care.
You are on Medicaid or Medi-Cal and were considering Midi.
Your history needs specialist coordination that has not been arranged.
You still cannot tell which path matches your situation → Find My HRT Path.

One last thing

Booking a first clinical visit is not a lifetime commitment to a treatment plan. Reading a refund policy before you pay is not pessimism. That is how grown-ups buy medicine.

You have done more homework than most women ever get the chance to do. You are not being difficult, and you are not overthinking it. The information was genuinely hard to compare because one service sells a bundled compounded product, the other sells clinical visits, and the public pages use numbers that do not describe the same purchase.

Now the next step is smaller than the research was.

Choose the next action that matches your situation
Have a PPO card and want a live clinician visit? → Check Midi’s current coverage and self-pay pricing (Midi may pay us a commission through a qualifying link.)
Want bundled cash-pay Oestra? → Read Inner Balance’s treatment details and refund policy before checkout. (Inner Balance pays us nothing on this page.)
Still torn or unsure whether online care is the right starting point? → Use Find My HRT Path.

Frequently asked questions

Is Inner Balance or Midi Health cheaper?

Over 90 days, Inner Balance is $597 if all three $199 monthly payments are collected for its shipped 90-day supply. Midi self-pay is $400 for an initial visit plus one continued-care visit, before medication and any labs. With PPO insurance, Midi may cost less, but your deductible, coinsurance, copay, and prescription determine the real total.

Does Midi Health take insurance?

Midi says it is in-network with most PPO plans. Coverage varies, and deductibles, coinsurance, and copays may apply. It cannot treat Medicaid or Medi-Cal patients, even as self-pay, and it is not covered by Medicare or Medicare-related plans.

Does Inner Balance take insurance?

No. Inner Balance says it does not bill commercial insurance, Medicare, or Medicaid. Its terms also say patients agree not to submit claims to private or government payers.

Is Oestra FDA-approved?

No. Oestra is a compounded finished product and is not FDA-approved. Estradiol and progesterone appear in FDA-approved medicines, but that does not give Oestra—or any other compounded finished product—FDA approval.

Is Midi Health FDA-approved?

A clinic is not “FDA-approved.” Specific drugs are. Midi commonly prescribes FDA-approved menopause products, but the exact status depends on the prescription, and Midi also offers compounded Custom Rx products and compounded testosterone.

Does either provider require lab work to start?

Inner Balance says routine labs are optional, although a clinician may order testing and extra costs may apply. Midi does not universally require hormone labs for general menopause care, but a clinician may order bloodwork or imaging. Midi’s testosterone pathway includes laboratory testing.

Can I use an HSA or FSA at Inner Balance or Midi?

Both advertise HSA/FSA payment options for eligible services. Inner Balance’s public pages conflict on whether an HSA/FSA-funded Oestra purchase is refundable under the six-month guarantee. Get that answer in writing before paying that way, and keep all documentation in case your plan administrator requests substantiation.

Is Inner Balance available in all 50 states?

Inner Balance’s terms say access is limited to U.S. states where its services are available. Confirm your state during intake rather than relying on a broad nationwide marketing phrase.

Is Midi Health available in all 50 states?

Midi advertises general menopause care nationwide, but individual insurance contracts, clinician availability, prescriptions, and specialized programs vary. Its women’s testosterone program was advertised in 25 states when verified on August 10, 2026.

Does Midi Health prescribe testosterone?

Yes, in its eligible states and when a clinician determines it is appropriate. Midi uses compounded testosterone for women. Testosterone is a Schedule III controlled substance, requires a prescription, and no testosterone product is FDA-approved specifically for menopausal symptoms in women in the United States.

Can I cancel Inner Balance at any time?

Inner Balance says you may cancel through the secure portal. Stopping future service is separate from requesting a refund. The refund policy requires the request within six months of the original order and within 14 days after cancellation.

How fast does Inner Balance ship?

Inner Balance says an approved prescription is compounded and shipped within 3–5 business days and typically arrives 3–5 business days after shipment. That is a provider-stated estimate, not a guaranteed delivery date.

How fast can I see a Midi clinician?

Appointment availability varies by state and clinician. Midi publishes a first-party testimonial mentioning a same-day appointment, but that is not a guarantee of typical availability. Check the live scheduler for your state.

Which one is better for perimenopause?

Midi is the better default if you are still figuring out the route, medication type, or whether hormones are appropriate. Inner Balance is the narrower fit if you specifically want Oestra’s compounded combined vaginal model and accept its cash-pay and product-status tradeoffs.

Which one is better if I have a uterus?

Neither company wins automatically. The key question is how the exact estrogen exposure is paired with adequate endometrial protection and what bleeding or monitoring plan applies. Ask the clinician to explain that for the exact product and dose—not hormone ingredients in the abstract.

Can I switch between them?

Yes, subject to clinician approval and state access. Bring your prescription label, dose, route, start date, treatment response, side effects, bleeding history, labs, and imaging. If leaving Inner Balance, check the refund deadlines before cancelling and submit the refund request separately.

What is the single biggest reason to choose Midi?

Broader clinical choice with a live visit and possible PPO coverage.

What is the single biggest reason to choose Inner Balance?

You specifically want its bundled combined compounded vaginal estradiol-and-progesterone format and prefer a published cash-pay subscription to insurance billing.

What is the biggest risk with each?

With Midi, it is insurance and billing uncertainty. With Inner Balance, it is committing money before clinician review while relying on compounded-product disclosures and refund terms that contain unresolved public-page conflicts.

Still not sure which HRT program is right for you? Take our free 60-second matching quiz. → Find My HRT Path

Primary-source ledger

Provider pricing, policies, access, and process — verified August 10, 2026

Medical and regulatory sources

Independent accountability records — snapshots verified August 10, 2026

This page is educational research, not medical advice, diagnosis, or a substitute for care from a licensed clinician. FDA-approved and compounded medications are labeled separately throughout. A compounded medication is not presented as safer than, more natural than, or equivalent to an FDA-approved finished product. Talk with a clinician who knows your history before starting, stopping, or changing hormone therapy.

Last verified: August 10, 2026.

Still comparing HRT care models?

Review the best online HRT providers, compare HRT costs in 2026, or use the free Find My HRT Path tool.

Keep reading: